RAPT Therapeutics (RAPT) Total Liabilities (2020 - 2024)
Historic Total Liabilities for Therapeutics (RAPT) over the last 5 years, with Q3 2024 value amounting to $13.0 million.
- Therapeutics' Total Liabilities fell 5186.29% to $13.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $13.0 million, marking a year-over-year decrease of 5186.29%. This contributed to the annual value of $26.3 million for FY2023, which is 2495.37% up from last year.
- Latest data reveals that Therapeutics reported Total Liabilities of $13.0 million as of Q3 2024, which was down 5186.29% from $18.0 million recorded in Q2 2024.
- Therapeutics' Total Liabilities' 5-year high stood at $27.9 million during Q1 2023, with a 5-year trough of $12.3 million in Q4 2021.
- In the last 5 years, Therapeutics' Total Liabilities had a median value of $19.0 million in 2020 and averaged $19.2 million.
- Per our database at Business Quant, Therapeutics' Total Liabilities soared by 7169.55% in 2022 and then tumbled by 5186.29% in 2024.
- Therapeutics' Total Liabilities (Quarter) stood at $14.8 million in 2020, then fell by 17.13% to $12.3 million in 2021, then skyrocketed by 71.7% to $21.0 million in 2022, then increased by 24.95% to $26.3 million in 2023, then crashed by 50.71% to $13.0 million in 2024.
- Its last three reported values are $13.0 million in Q3 2024, $18.0 million for Q2 2024, and $25.0 million during Q1 2024.